Advertisement.

TSBX Projected Dividend Yield

Turnstone Biologics Corp ( NASDAQ : TSBX )

Turnstone Biologics is engaged in the development of medicines to treat and cure patients with solid tumors. Co. is developing a differentiated approach to tumor infiltrating lymphocyte (TIL) therapies by selecting the potent, which able to mediate an anti-tumor response and tumor-reactive T cells. Co. has initiated two Phase 1 clinical trials for its Selected TIL product candidate, TIDAL-01, for the treatment of breast cancer, colorectal cancer, uveal melanoma and other non-cutaneous and cutaneous melanomas. Co. also advances on its preclinical pipeline programs including TIDAL-02, next Selected TIL program and TIDAL-01 viral immunotherapy combination program.

20 YEAR PERFORMANCE RESULTS

TSBX Dividend History Detail
TSBX Dividend News
TSBX Competitors News

# of Shares: 0

Closing Price: 0.48

Current Market Value: 0.00

Cost Basis: 0.00

Date Acquired:

Dividend Cash Flow
Year	Annual Dividend	Dividend Growth	# of Shares	Annual Dividend Income	Yield On Cost %
2014	0.00	0%	0	$ 0.00	0.00%
2015	0.00	0%	0	$ 0.00	0.00%
2016	0.00	0%	0	$ 0.00	0.00%
2017	0.00	0%	0	$ 0.00	0.00%
2018	0.00	0%	0	$ 0.00	0.00%
2019	0.00	0%	0	$ 0.00	0.00%
2020	0.00	0%	0	$ 0.00	0.00%
2021	0.00	0%	0	$ 0.00	0.00%
2022	0.00	0%	0	$ 0.00	0.00%
2023	0.00	0%	0	$ 0.00	0.00%
2024	0.00	0%	0	$ 0.00	0.00%
2025	0.00	0%	0	$ 0.00	0.00%
Using the current years Dividend Growth rate of 0% and projecting 0% forward the annual dividend income in 10/yrs would be $ 0.00 with a yield on cost % of 0.00%
Rolling Last 4 qtrs dividends total $ 0.00 and Previous last 4 qtrs dividends total $ 0.00
Dividend 1 Yr Growth = ( 0.00 – 0.00 ) × 100 = 0% (Click the Edit pencil if you want to modify the forward dividend growth rate projection) 0.00

Year	Declaration Date	Ex-Dividend Date	Record Date	Payable Date	Dividend $ Amount
Total:					0.0000